GB0913345D0 - New combination 802 - Google Patents
New combination 802Info
- Publication number
- GB0913345D0 GB0913345D0 GBGB0913345.5A GB0913345A GB0913345D0 GB 0913345 D0 GB0913345 D0 GB 0913345D0 GB 0913345 A GB0913345 A GB 0913345A GB 0913345 D0 GB0913345 D0 GB 0913345D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- new combination
- new
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0913345.5A GB0913345D0 (en) | 2009-07-31 | 2009-07-31 | New combination 802 |
PCT/GB2010/051243 WO2011012897A1 (en) | 2009-07-31 | 2010-07-29 | New combinations for the treatment of asthma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0913345.5A GB0913345D0 (en) | 2009-07-31 | 2009-07-31 | New combination 802 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0913345D0 true GB0913345D0 (en) | 2009-09-16 |
Family
ID=41129408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0913345.5A Ceased GB0913345D0 (en) | 2009-07-31 | 2009-07-31 | New combination 802 |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0913345D0 (en) |
WO (1) | WO2011012897A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2242759T1 (en) | 2008-02-06 | 2013-01-31 | Astrazeneca Ab | Compounds |
ITRM20110083U1 (en) | 2010-05-13 | 2011-11-14 | De La Cruz Jose Antonio Freire | PLATE FOR THE CONSTRUCTION OF TRUCKS FOR AIRPLANES |
EP2386555A1 (en) | 2010-05-13 | 2011-11-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities |
GB201016912D0 (en) | 2010-10-07 | 2010-11-24 | Astrazeneca Ab | Novel combination |
EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
ES2750523T3 (en) | 2012-12-18 | 2020-03-26 | Almirall Sa | Cyclohexyl and quinuclidinyl carbamate derivatives having beta2-adrenergic agonist and M3 muscarinic antagonist activities |
TWI643853B (en) | 2013-02-27 | 2018-12-11 | 阿爾米雷爾有限公司 | SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH β2 ADRENERGIC RECEPTOR AGONIST AND M3 MUSCARINIC RECEPTOR ANTAGONIST ACTIVITIES |
CN103141490B (en) * | 2013-03-06 | 2015-09-16 | 浙江省亚热带作物研究所 | N6-(2-ethoxy) adenosine is preparing the application in crop insecticide reagent |
TWI641373B (en) | 2013-07-25 | 2018-11-21 | 阿爾米雷爾有限公司 | SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH MUSCARINIC RECEPTOR ANTAGONIST AND β2 ADRENERGIC RECEPTOR AGONIST ACTIVITIES |
TW201517906A (en) | 2013-07-25 | 2015-05-16 | Almirall Sa | Combinations comprising MABA compounds and corticosteroids |
TW201617343A (en) | 2014-09-26 | 2016-05-16 | 阿爾米雷爾有限公司 | New bicyclic derivatives having [beta]2 adrenergic agonist and M3 muscarinic antagonist activities |
WO2017097568A1 (en) | 2015-12-09 | 2017-06-15 | Sabic Global Technologies B.V. | Process for the preparation of polyolefin-based graft copolymers comprising a first long chain branched polyolefin block and one or multiple polymer side chains |
US10787545B2 (en) | 2015-12-09 | 2020-09-29 | Sabic Global Technologies B.V. | Process for the preparation of polyolefin-based graft copolymers comprising a first functionalized short chain branched polyolefin block and one or multiple polymer side chains |
CN109195975B (en) * | 2016-09-30 | 2022-01-04 | 四川海思科制药有限公司 | Diazaspiro [5.5] undecane derivative and application thereof |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001038530A1 (en) | 1999-11-24 | 2001-05-31 | Takeda Chemical Industries, Ltd. | Use of disease-associated gene |
KR100468254B1 (en) | 1999-12-24 | 2005-01-27 | 에프. 호프만-라 로슈 아게 | Nitrile derivatives as cathepsin k inhibitors |
GB0003154D0 (en) | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
CO5300399A1 (en) | 2000-02-25 | 2003-07-31 | Astrazeneca Ab | HETEROCICLIOCS CONTAINING NITROGEN, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
AR028948A1 (en) | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | NEW COMPOUNDS |
DK1309591T3 (en) | 2000-08-14 | 2007-03-26 | Ortho Mcneil Pharm Inc | Substituted pyrazoles |
SE0100902D0 (en) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0102616D0 (en) | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
SE0102617D0 (en) | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
SE0104251D0 (en) | 2001-12-14 | 2001-12-14 | Astrazeneca Ab | Novel compounds |
SE0104331D0 (en) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Novel compounds |
AR038703A1 (en) | 2002-02-28 | 2005-01-26 | Novartis Ag | DERIVATIVES OF 5-PHENYLTIAZOL AND USE AS AN INHIBITOR OF QUINASA P I 3 |
AR039385A1 (en) | 2002-04-19 | 2005-02-16 | Astrazeneca Ab | THIOXANTINE DERIVATIVES AS INHIBITORS OF MIELOPEROXIDASA |
SE0300091D0 (en) | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
SE0300092D0 (en) | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
SE0301010D0 (en) | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
SE0301569D0 (en) | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
CN1835942A (en) | 2003-06-19 | 2006-09-20 | 金纳莱公司 | Mucin synthesis inhibitors |
EP1644326B1 (en) | 2003-06-30 | 2016-11-02 | Merck Canada Inc. | Cathepsin cysteine protease inhibitors |
SE0301963D0 (en) | 2003-07-02 | 2003-07-02 | Astrazeneca Ab | New compounds |
SA04250253B1 (en) | 2003-08-21 | 2009-11-10 | استرازينيكا ايه بي | Substiuted phenoxacetic as pharmaceutced compunds for treating respiratory diseases such as asthma and copd |
SE0302486D0 (en) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
GB0324790D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Amide derivatives |
AU2004293436B2 (en) | 2003-11-19 | 2010-12-09 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
ES2292130T3 (en) | 2004-05-04 | 2008-03-01 | Warner-Lambert Company Llc | PIRIDO (2,3-D) PIRIMIDIN-7-PIRROLIL-SUBSTITUTED WAVES AND DERIVED FROM THEMSELVES AS THERAPEUTIC AGENTS. |
SE0401762D0 (en) | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
MY140748A (en) | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
AU2005318292B2 (en) | 2004-12-23 | 2011-09-22 | Galderma Research & Development | Novel ligands that modulate RAR receptors, and use thereof in human medicine and in cosmetics |
WO2006091112A1 (en) | 2005-02-22 | 2006-08-31 | Genesis Reasearch And Development Corporation Limited | Compositions for the delivery of rna interference molecules and methods for their use |
US20070049591A1 (en) | 2005-08-25 | 2007-03-01 | Kalypsys, Inc. | Inhibitors of MAPK/Erk Kinase |
TW200738659A (en) | 2005-08-29 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200745003A (en) | 2005-10-06 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
JP2009523769A (en) | 2006-01-23 | 2009-06-25 | ラボラトワール セローノ ソシエテ アノニム | Thiazole derivatives and their use |
TW200745084A (en) * | 2006-03-08 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
TW200806667A (en) | 2006-04-13 | 2008-02-01 | Astrazeneca Ab | New compounds |
US7772233B2 (en) | 2006-04-19 | 2010-08-10 | Merck Serono, S.A. | Arylamino N-heteroaryl compounds as MEK inhibitors |
TW200808771A (en) | 2006-05-08 | 2008-02-16 | Astrazeneca Ab | Novel compounds II |
US20090264359A1 (en) | 2006-06-16 | 2009-10-22 | Cornelis Petrus Maria Van Kessel | Fplr-1 inhibitors for use in diseases involving amyloid-induced inflammatory events (flipr and flipr-like) and immunecomplex-mediated diseases |
CN101553493B (en) | 2006-07-19 | 2012-07-04 | 阿斯利康(瑞典)有限公司 | Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
TW200819430A (en) | 2006-09-07 | 2008-05-01 | Michael R Johnson | Enhanced mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
WO2008064136A2 (en) | 2006-11-17 | 2008-05-29 | Acadia Pharmaceuticals Inc. | Compounds with activity at retinoic acid receptors |
SE530201C2 (en) | 2006-12-18 | 2008-03-25 | Nilar Int Ab | Collision detecting circuit breaker system for battery stack in electric or hybrid vehicle, releases pressure applied to bipolar battery stack by strut in event of collision |
SA08280783B1 (en) | 2007-01-11 | 2011-04-24 | استرازينيكا ايه بي | Pyridopyrimidine Derivatives as PDE4 Inhibitors |
GB0703999D0 (en) * | 2007-03-01 | 2007-04-11 | Astrazeneca Ab | New combination 667 |
CA2691215C (en) | 2007-06-27 | 2016-03-29 | Astrazeneca Ab | Pyrazinone derivatives and their use in the treatment of lung diseases |
WO2009037503A2 (en) * | 2007-09-18 | 2009-03-26 | Astrazeneca Ab | New combination - 012 for the treatment of respiratory diseases |
CA2700181A1 (en) | 2007-10-04 | 2009-04-09 | Astrazeneca Ab | Steroidal [3, 2-c] pyrazole compounds, with glucocorticoid activity |
SI2242759T1 (en) * | 2008-02-06 | 2013-01-31 | Astrazeneca Ab | Compounds |
-
2009
- 2009-07-31 GB GBGB0913345.5A patent/GB0913345D0/en not_active Ceased
-
2010
- 2010-07-29 WO PCT/GB2010/051243 patent/WO2011012897A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011012897A1 (en) | 2011-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0913345D0 (en) | New combination 802 | |
GB0900404D0 (en) | New compounds 4 | |
GB0912946D0 (en) | New compounds 5 | |
GB0811099D0 (en) | New combination 376 | |
GB0900870D0 (en) | Loo 2 | |
EP2513131A4 (en) | Novel 3´-deoxy-3´-methylidene- -l-nucleosides | |
GB0808709D0 (en) | New combination 295 | |
GB0901941D0 (en) | 1007 | |
GB0902804D0 (en) | Fusebox 2 | |
GB0903160D0 (en) | Fusebox 4 | |
GB0916350D0 (en) | Flexi-bend 2000 | |
GB0921324D0 (en) | Guttergrow 2 | |
GB0916456D0 (en) | Concept 35 | |
GB0916464D0 (en) | Concept 43 | |
GB0911960D0 (en) | Concept 47 | |
GB0911961D0 (en) | Concept 48 | |
GB0916446D0 (en) | Concept 21 | |
GB0916447D0 (en) | Concept 22 | |
GB0916449D0 (en) | Concept 30 | |
GB0916450D0 (en) | Concept 29 | |
GB0916451D0 (en) | Concept 31 | |
GB0916452D0 (en) | Concept 32 | |
GB0916453D0 (en) | Concept 33 | |
GB0916455D0 (en) | Concept 34 | |
GB0916448D0 (en) | Concept 23 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |